Citation Impact

Citing Papers

The Caenorhabditis elegans vulval morphogenesis gene sqv - 4 encodes a UDP-glucose dehydrogenase that is temporally and spatially regulated
2002 StandoutNobel
Visualizing enveloping layer glycans during zebrafish early embryogenesis
2010 StandoutNobel
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
A Small-Molecule Modulator of Poly-α2,8-Sialic Acid Expression on Cultured Neurons and Tumor Cells
2001 StandoutScienceNobel
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Inhibition of Tumor Growth and Angiogenesis by Soluble EphB4
2004
Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures
2000
Pathways mediating VEGF-independent tumor angiogenesis
2009
The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development
2006
Chemical Technologies for Probing Glycans
2006 StandoutNobel
Angiopoietin and Tie signaling pathways in vascular development
2001
Getting the glycosylation right: Implications for the biotechnology industry
1996
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
2005
Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis
2003
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Alteration of Developmental and Pathological Retinal Angiogenesis in angptl4-deficient Mice
2011
Inhibition of Tumor Growth and Angiogenesis by Soluble EphB4
2004
Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer
2003
Angiogenesis in cancer and other diseases
2000 StandoutNature
The biology of VEGF and its receptors
2003 Standout
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Angiogenesis in health and disease
2003 Standout
Mechanisms of resistance to antiangiogenesis therapy
2010
Ten years of anti-vascular endothelial growth factor therapy
2016
Lymphangiogenesis in development and human disease
2005 StandoutNature
Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
2013
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes
2003 StandoutNatureNobel
The emerging roles of forkhead box (Fox) proteins in cancer
2007
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
2006
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Molecular regulation of vessel maturation
2003 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
2006 Nature
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
2016
Tie receptors: new modulators of angiogenic and lymphangiogenic responses
2001
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
Therapeutic targeting of the angiopoietin–TIE pathway
2017
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
2007
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Imaging of angiogenesis: from microscope to clinic
2003
Antiangiogenic therapies for high-grade glioma
2009
Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
2012
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression
2016
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
2018
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells
2002
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
2008
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
2009
Angiogenesis as a therapeutic target
2005 StandoutNature
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
2006
Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases
2016
A Genetic Approach to Mammalian Glycan Function
2003
Angiogenesis
2005
Suppression of the Raf/MEK/ERK Signaling Cascade and Inhibition of Angiogenesis by the Carboxyl Terminus of Angiopoietin-Like Protein 4
2008
In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish
2008 StandoutScienceNobel
Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells
2001
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
2007
The SQV-1 UDP-glucuronic acid decarboxylase and the SQV-7 nucleotide-sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development
2002 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Chemical Glycobiology
2001 StandoutScienceNobel
SQV-7, a protein involved in Caenorhabditis elegans epithelial invagination and early embryogenesis, transports UDP-glucuronic acid, UDP- N - acetylgalactosamine, and UDP-galactose
2001 StandoutNobel
Polymeric system for dual growth factor delivery
2001
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
2005
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells
2002
Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway
1999 StandoutNobel
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
2000
Cell Surface Engineering by a Modified Staudinger Reaction
2000 StandoutScienceNobel
Role of Glycosylation in Development
2004
sqv mutants of Caenorhabditis elegans are defective in vulval epithelial invagination
1999 StandoutNobel
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides
2003 StandoutNobel
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Imaging the glycome
2008 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450 BM3 demethylases
2009 StandoutNobel
Stabilized HIF‐1α is superior to VEGF for angiogenesis in skeletal muscle via adeno‐associated virus gene transfer
2005
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development
2004
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
Chemical Glycoproteomics
2016 StandoutNobel
Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases
2005
Protein N-Glycosylation: Molecular Genetics and Functional Significance
1998

Works of Ella Ioffe being referenced

Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)
2004
Absence of Soluble Leptin Receptor in Plasma fromdbPas/dbPas and Otherdb/db Mice
1998
Complex N-glycans in Mgat1 null preimplantation embryos arise from maternal Mgat1 RNA
1997
The anti-inflammatory actions of angiopoietin-1
2005
Suppression of Diabetic Retinopathy with Angiopoietin-1
2002
Angiopoietin-1 protects the adult vasculature against plasma leakage
2000
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
2006
VEGF-Trap: A VEGF blocker with potent antitumor effects
2002
Essential role for complex N-glycans in forming an organized layer of bronchial epithelium.
1996
Glycosyltransferase mutants: key to new insights in glycobiology
1995
Abnormal regulation of the leptin gene in the pathogenesis of obesity
1998
Rankless by CCL
2026